227 related articles for article (PubMed ID: 12194533)
1. Fifth-generation model for corticosteroid pharmacodynamics: application to steady-state receptor down-regulation and enzyme induction patterns during seven-day continuous infusion of methylprednisolone in rats.
Ramakrishnan R; DuBois DC; Almon RR; Pyszczynski NA; Jusko WJ
J Pharmacokinet Pharmacodyn; 2002 Feb; 29(1):1-24. PubMed ID: 12194533
[TBL] [Abstract][Full Text] [Related]
2. Pharmacodynamics and pharmacogenomics of methylprednisolone during 7-day infusions in rats.
Ramakrishnan R; DuBois DC; Almon RR; Pyszczynski NA; Jusko WJ
J Pharmacol Exp Ther; 2002 Jan; 300(1):245-56. PubMed ID: 11752123
[TBL] [Abstract][Full Text] [Related]
3. Fourth-generation model for corticosteroid pharmacodynamics: a model for methylprednisolone effects on receptor/gene-mediated glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.
Sun YN; DuBois DC; Almon RR; Jusko WJ
J Pharmacokinet Biopharm; 1998 Jun; 26(3):289-317. PubMed ID: 10098101
[TBL] [Abstract][Full Text] [Related]
4. Dose-dependence and repeated-dose studies for receptor/gene-mediated pharmacodynamics of methylprednisolone on glucocorticoid receptor down-regulation and tyrosine aminotransferase induction in rat liver.
Sun YN; DuBois DC; Almon RR; Pyszczynski NA; Jusko WJ
J Pharmacokinet Biopharm; 1998 Dec; 26(6):619-48. PubMed ID: 10485078
[TBL] [Abstract][Full Text] [Related]
5. Third-generation model for corticosteroid pharmacodynamics: roles of glucocorticoid receptor mRNA and tyrosine aminotransferase mRNA in rat liver.
Xu ZX; Sun YN; DuBois DC; Almon RR; Jusko WJ
J Pharmacokinet Biopharm; 1995 Apr; 23(2):163-81. PubMed ID: 8719235
[TBL] [Abstract][Full Text] [Related]
6. Receptor-mediated methylprednisolone pharmacodynamics in rats: steroid-induced receptor down-regulation.
Haughey DB; Jusko WJ
J Pharmacokinet Biopharm; 1992 Aug; 20(4):333-55. PubMed ID: 1362219
[TBL] [Abstract][Full Text] [Related]
7. Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part II: Sex Differences in Methylprednisolone Pharmacokinetics and Corticosterone Suppression.
Ayyar VS; DuBois DC; Nakamura T; Almon RR; Jusko WJ
J Pharmacol Exp Ther; 2019 Aug; 370(2):327-336. PubMed ID: 31197019
[TBL] [Abstract][Full Text] [Related]
8. Modeling receptor/gene-mediated effects of corticosteroids on hepatic tyrosine aminotransferase dynamics in rats: dual regulation by endogenous and exogenous corticosteroids.
Hazra A; Pyszczynski N; DuBois DC; Almon RR; Jusko WJ
J Pharmacokinet Pharmacodyn; 2007 Oct; 34(5):643-67. PubMed ID: 17593325
[TBL] [Abstract][Full Text] [Related]
9. Differential dynamics of receptor down-regulation and tyrosine aminotransferase induction following glucocorticoid treatment.
DuBois DC; Xu ZX; McKay L; Almon RR; Pyszcznski N; Jusko WJ
J Steroid Biochem Mol Biol; 1995 Sep; 54(5-6):237-43. PubMed ID: 7577705
[TBL] [Abstract][Full Text] [Related]
10. Pharmacodynamics of glucose regulation by methylprednisolone. I. Adrenalectomized rats.
Jin JY; Jusko WJ
Biopharm Drug Dispos; 2009 Jan; 30(1):21-34. PubMed ID: 19156931
[TBL] [Abstract][Full Text] [Related]
11. Meta-modeling of methylprednisolone effects on glucose regulation in rats.
Fang J; Sukumaran S; Dubois DC; Almon RR; Jusko WJ
PLoS One; 2013; 8(12):e81679. PubMed ID: 24312573
[TBL] [Abstract][Full Text] [Related]
12. Mathematical modeling of corticosteroid pharmacogenomics in rat muscle following acute and chronic methylprednisolone dosing.
Yao Z; Hoffman EP; Ghimbovschi S; Dubois DC; Almon RR; Jusko WJ
Mol Pharm; 2008; 5(2):328-39. PubMed ID: 18271548
[TBL] [Abstract][Full Text] [Related]
13. Receptor/gene/protein-mediated signaling connects methylprednisolone exposure to metabolic and immune-related pharmacodynamic actions in liver.
Ayyar VS; Sukumaran S; DuBois DC; Almon RR; Qu J; Jusko WJ
J Pharmacokinet Pharmacodyn; 2018 Aug; 45(4):557-575. PubMed ID: 29704219
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic/Pharmacodynamic models for corticosteroid receptor down-regulation and glutamine synthetase induction in rat skeletal muscle by a Receptor/Gene-mediated mechanism.
Sun YN; McKay LI; DuBois DC; Jusko WJ; Almon RR
J Pharmacol Exp Ther; 1999 Feb; 288(2):720-8. PubMed ID: 9918581
[TBL] [Abstract][Full Text] [Related]
15. Pharmacokinetics of methylprednisolone after intravenous and intramuscular administration in rats.
Hazra A; Pyszczynski N; DuBois DC; Almon RR; Jusko WJ
Biopharm Drug Dispos; 2007 Sep; 28(6):263-73. PubMed ID: 17569107
[TBL] [Abstract][Full Text] [Related]
16. Mechanistic Multi-Tissue Modeling of Glucocorticoid-Induced Leucine Zipper Regulation: Integrating Circadian Gene Expression with Receptor-Mediated Corticosteroid Pharmacodynamics.
Ayyar VS; DuBois DC; Almon RR; Jusko WJ
J Pharmacol Exp Ther; 2017 Oct; 363(1):45-57. PubMed ID: 28729456
[TBL] [Abstract][Full Text] [Related]
17. Receptor/gene-mediated pharmacodynamic effects of methylprednisolone on phosphoenolpyruvate carboxykinase regulation in rat liver.
Jin JY; DuBois DC; Almon RR; Jusko WJ
J Pharmacol Exp Ther; 2004 Apr; 309(1):328-39. PubMed ID: 14722324
[TBL] [Abstract][Full Text] [Related]
18. Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part III: Estrous Cycle and Estrogen Receptor-Dependent Antagonism of Glucocorticoid-Induced Leucine Zipper (GILZ) Enhancement by Corticosteroids.
Ayyar VS; DuBois DC; Almon RR; Jusko WJ
J Pharmacol Exp Ther; 2019 Aug; 370(2):337-349. PubMed ID: 31197018
[TBL] [Abstract][Full Text] [Related]
19. Modeling Corticosteroid Pharmacokinetics and Pharmacodynamics, Part I: Determination and Prediction of Dexamethasone and Methylprednisolone Tissue Binding in the Rat.
Ayyar VS; Song D; DuBois DC; Almon RR; Jusko WJ
J Pharmacol Exp Ther; 2019 Aug; 370(2):318-326. PubMed ID: 31197020
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic modeling of the effects of glucocorticoids and circadian rhythms on adipokine expression.
Sukumaran S; Jusko WJ; DuBois DC; Almon RR
J Pharmacol Exp Ther; 2011 Jun; 337(3):734-46. PubMed ID: 21398515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
